Genedx Holdings Corp (WGS) Stock Price, Quote & News

Company Profile

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 888 729 1206

Fax: 201 421 2010

Website: www.genedx.com

Address:

North Tower, 6th Floor 333 Ludlow Street, Stamford, United States

LewisDaKat Sep. 9 at 4:01 PM

$WGS GeneDx and Beren Therapeutics Launch NPC GenomeComplete to Improve Diagnosis of Niemann-Pick Disease Type C https://marketwirenews.com/stock/wgs/news/genedx-and-beren-therapeutics-launch-npc-genomecompl-5451761156061436.html?utm_source=stocktwits

0 · Reply

BB_88_ Sep. 9 at 3:26 PM

$WGS short tight stop

0 · Reply

GJ_Rockabilt Sep. 9 at 1:32 PM

$WGS Speaking of PDUFA Date, TLX has one the day after tomorrow on Sep 11th.

0 · Reply

11thestate Sep. 4 at 6:32 PM

When we see a stock like this, we know how many damaged investors are out there. Believe it or not, there’s some good news. $SMFR $WGS investors — you might be surprised, but you actually have a chance to recover your losses. Don’t miss it: https://11th.com/cases/sema4-investor-suit

0 · Reply

CarverX Sep. 1 at 11:12 PM

$WGS https://www.businesswire.com/news/home/20260901577181/en/ Nobody cares. 6 mos ago Time 100 was kiss of death. Get the ARR fine tuned and let’s fly Stue. Oh and buy some shares on open market 😎🚀🚀🚀

0 · Reply

11thestate Aug. 31 at 1:46 PM

CM Life Sciences now GeneDx Holdings ($WGS) investors, there’s no hidden secret here. Just one thing you really need to know. Here’s how to handle your losses. More importantly, how to either recover them or risk losing even more: https://11th.com/cases/cmls-investor-settlement

0 · Reply

BB_88_ Aug. 27 at 1:40 PM

$WGS short here day trade only

0 · Reply

Badinvestor50 Aug. 26 at 11:07 PM

$WGS damn sold this shit at $63. Big gains here rip

0 · Reply

CarverX Aug. 26 at 10:35 PM

$WGS Boom. 80 to 90 in one week 🚀🚀🚀

0 · Reply

Humtake Aug. 26 at 7:10 PM

$WGS I would like some thank yous from everyone for finally being impatient with the decline of this stock and selling a call at $95 a couple weeks ago since, you know, there is no way based on its performance that it would hit that. Which means by Sept 4th it's going to be above $95 so you are all welcome for the lift in ticker price. Stay tuned, once I BTC for a loss next week when it will undoubtedly be higher I may sell another call to try to make it back. I'll post the price so you can all know what price it will go above. WGS is pure trash.

1 · Reply

GeneDx, Beren Therapeutics launch NPC GenomeComplete

Sep 9, 2026, 8:30 AM EDT - 22 hours ago

GeneDx and Beren Therapeutics Launch NPC GenomeComplete to Improve Diagnosis of Niemann-Pick Disease Type C

Sep 8, 2026, 2:15 PM EDT - 1 day ago

GeneDx Holdings Transcript: Wells Fargo 21st Annual Healthcare Conference

Sep 1, 2026, 6:55 AM EDT - 9 days ago

GeneDx CEO Katherine Stueland Recognized as a 2026 Fierce 50 Honoree

2026-08-24T12:40:30.000Z - 16 days ago

GeneDx announces data published in Genetics in Medicine on genome sequencing

Aug 24, 2026, 8:30 AM EDT - 16 days ago

GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children's

Aug 11, 2026, 11:00 AM EDT - 4 weeks ago

GeneDx Holdings Transcript: Canaccord Genuity's 46th Annual Growth Conference

2026-08-11T12:41:16.000Z - 4 weeks ago

GeneDx launches new online offering to expand accessibility of exome testing

Aug 11, 2026, 8:30 AM EDT - 4 weeks ago

GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy

Aug 6, 2026, 4:05 PM EDT - 4 weeks ago

GeneDx to Participate in Upcoming Investor Conferences

2026-08-04T11:06:37.000Z - 5 weeks ago

GeneDx price target raised to $90 from $75 at Canaccord

Aug 3, 2026, 4:30 PM EDT - 5 weeks ago

GeneDx Holdings Earnings Call Transcript: Q2 2026

Aug 3, 2026, 4:30 PM EDT - 5 weeks ago

GeneDx Holdings Slides: Q2 2026

Aug 3, 2026, 4:30 PM EDT - 5 weeks ago

GeneDx Holdings Earnings release: Q2 2026

Aug 3, 2026, 4:30 PM EDT - 5 weeks ago

GeneDx Holdings Quarterly report: Q2 2026

Aug 3, 2026, 4:05 PM EDT - 5 weeks ago

GeneDx Reports Second Quarter 2026 Financial Results

Jul 30, 2026, 10:07 AM EDT - 5 weeks ago

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 3, 2026 in GeneDx Holdings Corp. Lawsuit - WGS

Jul 16, 2026, 4:05 PM EDT - 7 weeks ago

GeneDx to Report Second Quarter 2026 Financial Results on Monday, August 3, 2026

2026-07-15T12:50:47.000Z - 1 month ago

GeneDx price target raised to $85 from $55 at TD Cowen

Jul 1, 2026, 5:06 PM EDT - 2 months ago

WGS Stockholders Have Rights – If You Lost Money Investing in GeneDx Holdings Corp. Contact Robbins LLP for Information About Recovering Your Losses

2026-06-29T11:05:43.000Z - 2 months ago

GeneDx price target raised to $74 from $70 at Guggenheim

2026-06-23T11:03:08.000Z - 2 months ago

GeneDx price target raised to $63 from $50 at Piper Sandler

Jun 18, 2026, 9:00 AM EDT - 2 months ago

GeneDx Holdings Transcript: AGM 2026

2026-06-16T12:38:10.000Z - 2 months ago

GeneDx appoints Gardner as President

Jun 16, 2026, 8:30 AM EDT - 2 months ago

GeneDx Names Mark Gardner President to Lead Its Next Phase of Scale and Growth

Jun 15, 2026, 9:30 AM EDT - 2 months ago

Investor Notice of Barrack, Rodos & Bacine Concerning Its Lawsuit Against GeneDx Holdings Corp. (WGS)

Jun 10, 2026, 9:47 AM EDT - 3 months ago

GENEDX HOLDINGS CORP. (WGS) INVESTOR ALERT Investors With Large Losses in GeneDe Holdings Corp. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Jun 10, 2026, 8:27 AM EDT - 3 months ago

Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of GeneDx Holdings Corp. (WGS)

Jun 9, 2026, 8:00 AM EDT - 3 months ago

GeneDx Holdings Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 4, 2026, 3:30 PM EDT - 3 months ago

GeneDx Holdings (WGS) 49% Drop Triggers Investor Scrutiny Over Disconnect From Prior Growth Narrative- HBSS

May 26, 2026, 4:05 PM EDT - 3 months ago

GeneDx to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

May 20, 2026, 9:30 AM EDT - 3 months ago

Barrack, Rodos & Bacine Investigates GeneDx Holdings Corp. (NASDAQ: WGS) For Possible Securities Fraud

2026-05-05T12:38:23.000Z - 4 months ago

GeneDx price target lowered to $85 from $153 at Craig-Hallum

May 5, 2026, 8:09 AM EDT - 4 months ago

GeneDx Holdings Corp. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

2026-05-05T12:02:38.000Z - 4 months ago

GeneDx price target lowered to $55 from $60 at TD Cowen

2026-05-05T11:43:37.000Z - 4 months ago

GeneDx price target lowered to $90 from $170 at BTIG, removed from Top Picks

2026-05-05T11:27:49.000Z - 4 months ago

GeneDx price target lowered to $70 from $100 at Guggenheim

May 4, 2026, 4:30 PM EDT - 4 months ago

GeneDx Holdings Earnings Call Transcript: Q1 2026

May 4, 2026, 4:30 PM EDT - 4 months ago

GeneDx Holdings Slides: Q1 2026

May 4, 2026, 4:30 PM EDT - 4 months ago

GeneDx Holdings Earnings release: Q1 2026

May 4, 2026, 4:30 PM EDT - 4 months ago

GeneDx Holdings Quarterly report: Q1 2026

May 4, 2026, 4:05 PM EDT - 4 months ago

GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year Outlook

Apr 30, 2026, 8:00 AM EDT - 4 months ago

GeneDx Holdings Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 4 months ago

GeneDx Holdings Proxy statement: Proxy filing

Apr 13, 2026, 4:05 PM EDT - 4 months ago

GeneDx to Report First Quarter 2026 Financial Results on Monday, May 4, 2026

Mar 11, 2026, 5:00 PM EDT - 6 months ago

Landmark Study Shows Average Cost Savings of $80,000 Per Child and Overall Improved Health Outcomes Following GeneDx Exome and Genome Testing

Mar 11, 2026, 3:00 PM EDT - 6 months ago

GeneDx Holdings Transcript: Barclays 28th Annual Global Healthcare Conference

Mar 10, 2026, 8:30 AM EDT - 6 months ago

GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C

Mar 9, 2026, 8:30 AM EDT - 6 months ago

GeneDx to Present 18 Abstracts at ACMG 2026, Showcasing the Scale of GeneDx Infinity™ and Real-World Genomic Leadership

Feb 25, 2026, 8:03 PM EST - 6 months ago

HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Feb 23, 2026, 8:30 AM EST - 6 months ago

GeneDx Holdings Earnings Call Transcript: Q4 2025

Feb 23, 2026, 8:30 AM EST - 6 months ago

GeneDx Holdings Annual report: Q4 2025

Feb 23, 2026, 8:30 AM EST - 6 months ago

GeneDx Holdings Earnings release: Q4 2025

Feb 23, 2026, 8:30 AM EST - 6 months ago

GeneDx Holdings Slides: Q4 2025

Feb 23, 2026, 8:07 AM EST - 6 months ago

INSERTING and REPLACING GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026

Feb 23, 2026, 6:30 AM EST - 6 months ago

GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026

Feb 11, 2026, 9:05 AM EST - 7 months ago

TIME Names GeneDx CEO Katherine Stueland to the 2026 TIME100 Health List of the World's Most Influential Leaders in Health

Feb 3, 2026, 8:00 AM EST - 7 months ago

GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026

Jan 15, 2026, 11:24 AM EST - 7 months ago

Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights

Jan 14, 2026, 6:00 PM EST - 7 months ago

GeneDx Holdings Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 6:00 PM EST - 7 months ago

GeneDx Holdings Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 3:03 PM EST - 8 months ago

Why is GeneDx stock crashing on Monday?

Jan 12, 2026, 7:30 AM EST - 8 months ago

GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance

Jan 8, 2026, 8:30 AM EST - 8 months ago

GeneDx and Komodo Health Partner to Build the World's Most Complete Longitudinal Rare Disease Dataset

LewisDaKat Sep. 9 at 4:01 PM

0 · Reply

BB_88_ Sep. 9 at 3:26 PM

$WGS short tight stop

0 · Reply

GJ_Rockabilt Sep. 9 at 1:32 PM

$WGS Speaking of PDUFA Date, TLX has one the day after tomorrow on Sep 11th.

0 · Reply

11thestate Sep. 4 at 6:32 PM

0 · Reply

CarverX Sep. 1 at 11:12 PM

0 · Reply

11thestate Aug. 31 at 1:46 PM

0 · Reply

BB_88_ Aug. 27 at 1:40 PM

$WGS short here day trade only

0 · Reply

Badinvestor50 Aug. 26 at 11:07 PM

$WGS damn sold this shit at $63. Big gains here rip

0 · Reply

CarverX Aug. 26 at 10:35 PM

$WGS Boom. 80 to 90 in one week 🚀🚀🚀

0 · Reply

Humtake Aug. 26 at 7:10 PM

1 · Reply

BB_88_ Aug. 26 at 4:32 PM

$WGS short 89

1 · Reply

BB_88_ Aug. 26 at 3:07 PM

$WGS short day trade only

0 · Reply

CarverX Aug. 25 at 4:55 PM

$WGS

0 · Reply

CarverX Aug. 25 at 3:51 PM

$WGS $TEM $GRAL Genetic testing having another strong day 🚀🚀🚀

0 · Reply

CarverX Aug. 23 at 6:55 PM

$WGS

0 · Reply

007G Aug. 23 at 10:54 AM

$WGS Will still fall deep

0 · Reply

MikeJonesSwishaHouse Aug. 21 at 9:43 PM

$WGS looking to enter next week. Just exited PSNL at a nice 160% gain. Loving the genomics/testing theme lately!

0 · Reply

CarverX Aug. 21 at 4:36 PM

$TEM $WGS Tem on a run 🚀🚀🚀

0 · Reply

CarverX Aug. 21 at 4:35 PM

$WGS Strong like bull🚀🚀🚀

0 · Reply

CarverX Aug. 20 at 7:31 PM

$WGS Pushing up to next Fibonacci retrace at 84. Golden cross of 50 and 100 approaching. Technicals are lining up 🚀🚀🚀

0 · Reply

11thestate Aug. 20 at 12:29 PM

$SMFR (now $WGS ) stock dropped 33% after Sema4 announced major changes to its strategy and workforce, ending up in a $4.75 million investor settlement. If you bought or held $SMFR in 2022, you may still be able to recover losses as claims are currently open: https://11th.com/cases/sema4-investor-suit

0 · Reply

CarverX Aug. 19 at 3:47 PM

$WGS $TEM $GRAL Biotech booming today off moderna trial 🚀🚀🚀

0 · Reply

Market Cap	2.56B
Revenue (ttm)	427.54M
Net Income (ttm)	-21.02M
EPS (ttm)	N/A
PE Ratio	238.86
Forward PE	N/A
Profit Margin	-4.92%
Debt to Equity Ratio	0.40

Volume	493,000
Avg Vol	678,714
Day's Range	N/A - N/A
Shares Out	29.82M
Stochastic %K	50%
Beta	1.99
Analysts	Strong Sell
Price Target	$90.44